This isn’t FIBROBIOLOGICS’s most recent raise. Reg CF · Preferred Stock · Feb 2023 (Closed) is more current.View latest round

Section 4(a)(2) · Preferred Stock · Dec 2022

ClosedOtherPreferred Equity

via the platform · last checked Oct 5, 2026

Raised

$2.2M

Investors

—

Estimated pre-money

$159M

—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$159M

Price / share$1.4083

Price / share today$5.6332

Estimated, not stated: $1.4083 × 112,922,658 securities outstanding as of Dec 31, 2022 (Form C-AR filed May 1, 2023, p. 38).

$1.4083 as sold; $5.6332 after the Oct 2023 split (1:4) (Form 10-K, p. 1).

Offering details

Target—

Max—

Min investment—

OpenedDec 23, 2022

Deadline—

ClosedDec 23, 2022

Days active1

Links & provenance

SEC filing

Source: SEC EDGAR
Last synced Oct 5, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.